What are the symptoms of an overdose of Montair LC Kids (levocetirizine and montelukast)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Montair LC Kids Overdose

In the event of Montair LC Kids (montelukast + levocetirizine) overdose, the most frequently occurring symptoms include abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity, though the majority of overdose cases have been asymptomatic. 1

Montelukast Component Overdose Symptoms

The montelukast component has demonstrated a remarkably safe overdose profile based on FDA drug labeling data:

  • Most overdose cases are asymptomatic - the majority of reported overdoses produced no adverse experiences 1
  • Abdominal pain is among the most common symptoms when they do occur 1
  • Somnolence (drowsiness) may develop 1
  • Thirst has been reported 1
  • Headache can occur 1
  • Vomiting may be present 1
  • Psychomotor hyperactivity (increased restlessness and activity) 1

The FDA reports that montelukast has been studied at doses up to 200 mg/day for 22 weeks and up to 900 mg/day for approximately one week without clinically important adverse experiences in adults 1. Post-marketing overdose reports include doses as high as 1000 mg, with clinical findings consistent with the known safety profile 1.

Levocetirizine Component Overdose Symptoms

While specific overdose data for levocetirizine in the provided evidence is limited, antihistamine overdoses typically present with:

  • Somnolence and sedation - this is the primary concern with antihistamine overdose
  • Potential for paradoxical agitation in children, though this is more common with first-generation antihistamines

Management Approach

Employ usual supportive measures including removal of unabsorbed material from the gastrointestinal tract, clinical monitoring, and supportive therapy as required 1:

  • Remove unabsorbed drug from the gastrointestinal tract if presentation is early 1
  • Institute clinical monitoring for symptom development 1
  • Provide supportive therapy as needed based on symptoms 1
  • No specific antidote exists for either component 1

Important Clinical Considerations

  • Dialysis is not helpful - it is unknown whether montelukast is removed by peritoneal dialysis or hemodialysis 1
  • Symptoms are generally self-limited and resolve with supportive care 1
  • The combination is generally well-tolerated even in overdose scenarios, with serious toxicity being rare 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.